Clinical Trial Update: Radiation Therapy Plus Porfiromycin in Treating Patients With Stage III or Stage IV Head and Neck Cancer [Phase 3]

View source ↗

Summary

A completed Phase 3 clinical trial evaluated radiation therapy plus porfiromycin for stage III or IV head and neck cancer, sponsored by Boehringer Ingelheim.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Drugs mentioned

• Porfiromycin (porfiromycin)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Head and Neck Cancer | Phase 3 | Status: COMPLETED